# UK Advanced Wound Therapy Devices Market > UK Advanced Wound Therapy Devices Market Research Report By Type (Negative pressure wound therapy systems, Electric stimulation devices, Hyperbaric oxygen equipment, Pressure relief devices, Others) and By End User (Hospitals and amp; clinics, Home care settings, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.49% - **2024:** $ 550 Million - **2025:** $ 580.2 Million - **2035:** $ 990 Million - **Key Players:** Smith & Nephew (GB), Mölnlycke Health Care (SE), Acelity (US), Convatec (GB), 3M (US), Medtronic (IE), Hollister Incorporated (US), B. Braun Melsungen AG (DE), Coloplast (DK) **Report ID:** MRFR/Pharma/51094-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** August 07, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-advanced-wound-therapy-devices-market-52855 --- ## Market Summary ## **UK Advanced Wound Therapy Devices Market Overview** As per MRFR analysis, the UK Advanced Wound Therapy Devices Market Size was estimated at 522.06 (USD Million) in 2023. The UK Advanced Wound Therapy Devices Market Industry is expected to grow from 550.44(USD Million) in 2024 to 1,038 (USD Million) by 2035. The UK Advanced Wound Therapy Devices Market CAGR (growth rate) is expected to be around 5.936% during the forecast period (2025 - 2035). ## **Key UK Advanced Wound Therapy Devices Market Trends Highlighted** The UK Advanced Wound Therapy Devices Market is experiencing significant growth, primarily driven by the rising prevalence of chronic wounds such as diabetic ulcers and pressure sores. The National Health Service (NHS) has identified chronic wound management as a key area for improving patient care, leading to increased investments in advanced therapy devices.  Additionally, the aging population in the UK is contributing to a higher demand for effective wound care solutions, as older individuals tend to experience more chronic wounds and slower healing processes. Opportunities within the UK market are emerging as healthcare providers increasingly adopt innovative technologies, such as bioengineered skin substitutes and negative pressure wound therapy. To improve patient outcomes and management, telehealth and remote monitoring, among other digital health solutions, are being implemented. Additionally, there is an emerging focus on individualized patient wound care therapy, representing a more patient-centered paradigm shift within this therapeutic area.  Recently, there has been an increase in attention to infection control and antimicrobial stewardship, driving the need for more sophisticated wounds requiring advanced healing with antimicrobial technology. The UK government supports this initiative through funding and providing guidelines to enhance research and development in advanced wound care therapeutics.The trend of sustainability is also gaining traction, with manufacturers looking to develop eco-friendly packaging and materials for advanced wound therapy devices.  This shift aligns with the wider UK NHS sustainability goals, which aim to reduce carbon footprints and waste in the healthcare sector. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ## **UK Advanced Wound Therapy Devices Market Drivers** ### **Rising Incidence of Diabetes and Related Complications** The UK Advanced Wound Therapy Devices Market Industry is being significantly driven by the increasing prevalence of diabetes, which affects around 3.9 million people in the UK, according to the National Health Service (NHS). The diabetes population is expected to rise dramatically, leading to a corresponding increase in diabetic foot ulcers and wounds that require advanced therapy solutions.  The cost of diabetic complications is substantial, estimated at 13.5 billion annually for the UK healthcare system, further stressing the need for effective wound care solutions.This scenario presents a considerable market opportunity for companies specializing in advanced wound therapy devices, such as Smith & Nephew and Mlnlycke Health Care, which have been enhancing their portfolios to address this growing patient need. ### **Technological Advancements in Wound Care** Continuous innovations in technology, particularly in regenerative medicine and biomaterials, are propelling the UK Advanced Wound Therapy Devices Market Industry forward. Recent advancements, such as the development of skin substitutes and intelligent dressings that monitor wound conditions in real time, are enhancing treatment efficiency.  Established companies like Convatec are investing heavily in Research and Development (R&D) to introduce state-of-the-art products that improve healing rates.As the demand for effective treatment grows, supported by improved outcomes, the market is positioned to experience robust growth due to these technological advancements. ### **Increase in Aging Population** The aging population in the UK is contributing to the growth of the UK Advanced Wound Therapy Devices Market. By 2030, it is estimated that one in five people in the UK will be aged 65 and over. This demographic is more susceptible to chronic wounds due to various age-related conditions, such as reduced mobility and skin integrity.  For instance, the Care Quality Commission reports a significant rise in chronic ulcers among the elderly population, creating a demand for advanced wound therapy devices.Organizations like the British Geriatrics Society are focusing on improving healthcare for older adults, thereby driving investments in wound management solutions. ### **Government Initiatives and Funding** Government initiatives aimed at improving wound care services are fostering growth in the UK Advanced Wound Therapy Devices Market. The NHS has made significant commitments to enhancing wound care management, recognizing it as a priority area. The introduction of programs focused on reducing preventable complications and hospital readmissions has led to increased funding for advanced therapies.  The value of such investments is reflected in recent NHS guidelines emphasizing the need for innovation in wound management practices.Companies like Hartmann Group have been actively collaborating with public health authorities to align their product offerings with these initiatives, thus creating a favorable environment for market expansion. ## **UK Advanced Wound Therapy Devices Market Segment Insights** ### **Advanced Wound Therapy Devices Market Type Insights** The UK Advanced Wound Therapy Devices Market exhibits diverse types catering to various wound care needs, reflecting a significant part of healthcare management in the region. Among the prominent types, Negative Pressure Wound Therapy (NPWT) systems have emerged as a leading approach, recognized for their capability to promote healing through the application of sub-atmospheric pressure, thus effectively managing chronic and acute wounds.  This category continues to dominate the market due to its proven efficacy in reducing wound healing times and minimizing infection rates, making it integral in both hospital settings and at-home care.Electric stimulation devices are gaining traction as a valuable tool in the market, utilizing electrical currents to stimulate cellular processes that accelerate wound healing, representing a forward-thinking approach to tissue repair and regeneration.  Hyperbaric oxygen equipment also plays a critical role, particularly for specific indications such as diabetic foot ulcers and other complex wounds, as it enhances oxygen delivery to tissues, thereby improving healing outcomes. Pressure relief devices are vital in preventing pressure ulcers, especially in patients with limited mobility, highlighting the importance of preventive care in wound management strategies. The collective presence of these categories showcases a comprehensive landscape of the UK Advanced Wound Therapy Devices Market, where each type addresses unique patient needs and underscores the importance of innovative solutions in wound care management.  The ongoing advancements in wound care technology, alongside increasing healthcare investments and the aging population in the UK, are driving growth opportunities within these segments. As healthcare providers continue to adopt and integrate these devices into their practices, the UK Advanced Wound Therapy Devices Market is poised for progressive evolution, aimed at improving patient outcomes and streamlining treatment protocols across the healthcare spectrum. Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review** ### **Advanced Wound Therapy Devices Market End User Insights** The UK Advanced Wound Therapy Devices Market showcases a diverse End User segmentation that plays a critical role in the healthcare landscape. Hospitals and clinics are pivotal in delivering advanced wound care, utilizing innovative therapies to manage chronic and complex wounds effectively. These facilities often have access to the latest technology and specialized staff trained in advanced treatment protocols. Home care settings have emerged as a significant segment as well, driven by the increasing preference for at-home treatment and the aging population requiring ongoing care from comfortable environments. This shift reflects broader trends in healthcare, emphasizing personalized and patient-centered approaches to treatment. Other facilities, such as rehabilitation centers and long-term care institutions, also contribute to the landscape, providing essential wound care services to their residents. The growing focus on wound care management and patient outcomes underscores the importance of each of these segments in optimizing care delivery and improving the quality of life for patients, positioned in a market that is expected to evolve continuously in response to technological advancements and changing healthcare demands in the UK. ## **UK Advanced Wound Therapy Devices Market Key Players and Competitive Insights** The UK Advanced Wound Therapy Devices Market has become increasingly competitive, driven by an aging population, a rise in chronic wounds, and advancements in technology that improve patient outcomes. The landscape is characterized by numerous manufacturers and suppliers offering innovative solutions that address the diverse needs of healthcare providers and patients. Companies are focused on developing advanced technologies such as negative pressure wound therapy, bioactive dressings, and other specialized products that not only enhance healing but also reduce the overall burden on healthcare systems.  As a result, the market is seeing heightened competition, with organizations continually striving to strengthen their market position through research and development, strategic partnerships, and an emphasis on customer satisfaction.Systagenix stands out in the UK Advanced Wound Therapy Devices Market due to its significant focus on providing high-quality advanced wound care solutions specifically tailored to meet the needs of healthcare professionals and patients. The company is recognized for its innovative approach to wound healing, incorporating advanced technologies into its product offerings.  Systagenix's strengths lie in its dedication to research and development, ensuring that its product range remains at the forefront of the market. The company's strong presence in the UK is supported by comprehensive training programs for healthcare providers, empowering them with the knowledge and skills necessary to utilize Systagenix products effectively. This commitment to quality and education has positioned Systagenix as a trusted partner in wound care, enabling it to establish strong relationships within the healthcare community. Coloplast is another prominent player in the UK Advanced Wound Therapy Devices Market, distinguished by its extensive product range that includes advanced wound dressings and innovative solutions for both acute and chronic wound management. The company focuses on patient-centered care, prioritizing the development of products that enhance comfort and ease of use for both patients and healthcare professionals.  Coloplast has made strategic investments in mergers and acquisitions, allowing it to broaden its market presence and leverage synergies that enhance its product offerings. Key services provided by Coloplast include comprehensive product training and customer support that cater specifically to the UK market's needs.  By maintaining a strong commitment to innovation and ensuring swift access to its latest products, Coloplast has garnered a solid reputation and increased its influence within the UK wound care landscape, positioning itself as a leader in advanced wound therapy solutions. ### **Key Companies in the UK Advanced Wound Therapy Devices Market Include:** ## **UK Advanced Wound Therapy Devices Market Industry Developments** In recent developments within the UK Advanced Wound Therapy Devices Market, companies like Smith and Nephew and Coloplast have made significant strides in expanding their product portfolios, particularly focusing on innovative therapies that address chronic wound care. Notably, in September 2023, ConvaTec announced the acquisition of the wound care division of a smaller firm, enhancing its presence in this competitive sector. This move aligns with the broader trend of consolidation in the market, as companies aim to leverage advanced technologies to improve patient outcomes.  In addition, Medtronic revealed an increase in market valuation driven by extensive Research and Development investments, indicating a robust commitment to enhancing advanced wound management solutions. The market is also witnessing growth, with estimates suggesting a surge in demand due to rising incidences of chronic wounds, which has propelled organizations like 3M and Hollister to invest further in advanced products.  Over the past two years, significant events include ECM Medical's launch of a novel wound healing device in January 2022, showcasing the innovations aimed at addressing various wound care challenges within the UK's healthcare framework. ## **UK Advanced Wound Therapy Devices Market Segmentation Insights** ### **Advanced Wound Therapy Devices Market Type Outlook** ### **Advanced Wound Therapy Devices Market End User Outlook** - Hospitals & clinics - Home care settings ## Market Drivers ### Supportive Government Policies Supportive government policies are significantly influencing the advanced wound-therapy-devices market in the UK. The government is actively promoting the adoption of advanced medical technologies through various initiatives and funding programs. These policies aim to enhance healthcare delivery and improve patient outcomes, particularly in the realm of wound care. By providing financial incentives and grants for healthcare facilities to invest in advanced wound-therapy devices, the government is fostering an environment conducive to innovation and growth. Additionally, regulatory frameworks are being streamlined to facilitate the introduction of new technologies into the market. This supportive landscape not only encourages manufacturers to develop cutting-edge solutions but also ensures that healthcare providers have access to the latest advancements in wound care, ultimately benefiting patients. ### Growing Awareness of Wound Care There is a notable increase in awareness regarding wound care among both healthcare professionals and patients in the UK. Educational initiatives and training programs are being implemented to inform stakeholders about the benefits of advanced wound-therapy devices. This heightened awareness is crucial, as it encourages the adoption of innovative treatment options that can lead to improved healing outcomes. Furthermore, patient education on wound management is empowering individuals to seek timely medical intervention, thereby reducing the risk of complications associated with untreated wounds. As awareness continues to grow, the demand for advanced wound-therapy devices is likely to rise, fostering a more proactive approach to wound care. This cultural shift towards prioritizing effective wound management is expected to have a lasting impact on the market. ### Increased Healthcare Expenditure The advanced wound-therapy-devices market is benefiting from the rising healthcare expenditure in the UK. The government has been increasing its investment in healthcare services, with a focus on improving patient outcomes and reducing the burden of chronic diseases. In recent years, healthcare spending has risen by approximately 4-5 % annually, which has led to enhanced funding for advanced wound care technologies. This financial support enables healthcare facilities to acquire state-of-the-art devices that can significantly improve wound healing processes. As hospitals and clinics adopt these advanced solutions, the overall efficiency of wound management is likely to improve, resulting in better patient care and reduced healthcare costs in the long run. The emphasis on quality care and effective treatment options is expected to drive further growth in the advanced wound-therapy-devices market. ### Rising Incidence of Chronic Wounds The advanced wound-therapy-devices market in the UK is experiencing growth due to the increasing prevalence of chronic wounds, such as diabetic ulcers and pressure sores. According to recent data, chronic wounds affect approximately 1-2 % of the population, leading to a heightened demand for effective treatment solutions. This trend is further exacerbated by an aging population, which is more susceptible to such conditions. The need for advanced wound care technologies is becoming critical, as traditional methods often prove inadequate. Consequently, healthcare providers are increasingly adopting advanced wound-therapy devices to enhance patient outcomes and reduce healing times. This shift not only improves the quality of care but also alleviates the financial burden on the healthcare system, as effective wound management can significantly lower treatment costs associated with prolonged hospital stays. ### Technological Innovations in Wound Care Technological advancements play a pivotal role in shaping the advanced wound-therapy-devices market. Innovations such as bioengineered skin substitutes, negative pressure wound therapy, and smart dressings are revolutionizing wound management. These technologies enhance healing rates and improve patient comfort, which is crucial in a healthcare landscape that prioritizes patient-centric care. The market is projected to grow at a CAGR of around 6-8 % over the next few years, driven by these innovations. Furthermore, the integration of digital health technologies, such as telemedicine and remote monitoring, is likely to facilitate better management of wound care, allowing healthcare professionals to monitor patients' progress in real-time. This technological evolution not only optimizes treatment protocols but also empowers patients, making them active participants in their healing process. ## Future Outlook The [Advanced Wound Therapy Devices Market](https://www.marketresearchfuture.com/reports/advanced-wound-therapy-devices-market-7421) is projected to grow at a 5.49% CAGR from 2025 to 2035, driven by technological advancements, increasing chronic wound prevalence, and rising healthcare expenditure. **New opportunities:** - Development of portable wound-care devices for home use - Integration of AI for personalized wound management solutions - Expansion of telehealth services for remote patient monitoring By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand. ## Segment Insights ### By Type: Negative Pressure Wound Therapy Systems (Largest) vs. Electric Stimulation Devices (Fastest-Growing) In the UK advanced wound-therapy-devices market, the distribution of market share reveals that Negative Pressure Wound Therapy Systems dominate with a considerable share, largely attributed to their effectiveness in promoting wound healing and reducing infection risks. Electric Stimulation Devices, while currently smaller in market share, are rapidly gaining traction due to their innovative approach in pain management and tissue repair. The growth trends suggest a robust expansion in the advanced wound-therapy-devices sector, driven by increasing incidences of wounds related to chronic diseases and surgeries. Moreover, advancements in technology and materials are enhancing device efficacy and patient outcomes. The evolving healthcare landscape prioritizes effective healing solutions, further propelling the uptake of Electric Stimulation Devices in clinical settings, making them an emerging player in this market. Technology: Negative Pressure Wound Therapy Systems (Dominant) vs. Electric Stimulation Devices (Emerging) Negative Pressure Wound Therapy Systems hold a dominant position in the UK advanced wound-therapy-devices market due to their ability to create a vacuum that draws out fluid and promotes healing. These devices are widely used in hospital settings and have established a strong user base, benefiting from clinical evidence supporting their effectiveness. In contrast, Electric Stimulation Devices are emerging due to their innovative therapeutic applications, which stimulate cellular activity and accelerate tissue regeneration. The adoption of these devices is growing as healthcare providers seek alternative, non-invasive treatment options to enhance patient recovery. Innovations in Electric Stimulation Devices continue to drive their market growth, establishing them as a significant competitor in the wound care landscape. ### By End-user: Hospitals & Clinics (Largest) vs. Home Care Settings (Fastest-Growing) In the UK advanced wound-therapy-devices market, the 'End-user' segment is primarily dominated by Hospitals & Clinics, which capture a significant share of the overall market distribution. This established segment benefits from a high demand for advanced wound care devices due to an increasing number of surgical procedures and hospital admissions. Conversely, Home Care Settings are progressively capturing market presence, driven by a shift towards outpatient care and an increasing focus on patient comfort and convenience, making this segment a focal point for growth. The growth trends within this segment are largely influenced by technological advancements and the rising awareness of chronic wounds. Hospitals & Clinics remain stable with continuous investment in healthcare infrastructure, while Home Care Settings are emerging rapidly due to patients' preference for at-home treatment options. This transition is supported by innovative product offerings that enhance healing outcomes and facilitate easier monitoring of the wound care process, driving increased adoption in both traditional and home-based care environments. Hospitals & Clinics (Dominant) vs. Home Care Settings (Emerging) Hospitals & Clinics serve as the dominant force within the UK advanced wound-therapy-devices market due to their comprehensive resources and capabilities to provide extensive medical care. They benefit from established routines and protocols, ensuring patients receive timely and effective treatment. Advanced wound-care technologies in this segment are often integrated into broader therapeutic practices. On the other hand, Home Care Settings are emerging as vital players in wound care, propelled by the ongoing shift towards patient-centric care models. This segment is characterized by increasing patient autonomy and a trend towards utilizing telemedicine and portable wound-care devices, making treatment more accessible and manageable at home. The proliferation of home healthcare services further supports the growth and innovation within this segment. ## Competitive Benchmarking The advanced wound-therapy-devices market in the UK is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include an increasing prevalence of chronic wounds, an aging population, and advancements in technology that enhance treatment efficacy. Major players such as Smith & Nephew (GB), Mölnlycke Health Care (SE), and Convatec (GB) are strategically positioned to leverage these trends. Smith & Nephew (GB) focuses on innovation through the development of advanced products, while Mölnlycke Health Care (SE) emphasizes partnerships to expand its product offerings. Convatec (GB) is actively pursuing digital transformation initiatives to improve patient outcomes, collectively shaping a competitive environment that prioritizes innovation and strategic collaborations.In terms of business tactics, companies are increasingly localizing manufacturing to enhance supply chain efficiency and reduce costs. The market appears moderately fragmented, with several key players exerting influence over specific segments. This fragmentation allows for niche players to thrive, while larger companies consolidate their market share through strategic acquisitions and partnerships. The collective influence of these key players fosters a competitive structure that encourages continuous improvement and innovation. In October Smith & Nephew (GB) announced the launch of a new advanced wound dressing that incorporates antimicrobial technology, aimed at reducing infection rates in chronic wounds. This strategic move not only enhances their product portfolio but also positions the company as a leader in infection management, a critical concern in wound care. The introduction of such innovative solutions is likely to strengthen their market presence and appeal to healthcare providers seeking effective treatment options. In September Mölnlycke Health Care (SE) entered into a strategic partnership with a leading digital health company to integrate AI-driven analytics into their wound management solutions. This collaboration is expected to enhance patient monitoring and treatment personalization, reflecting a growing trend towards digitalization in healthcare. By leveraging AI, Mölnlycke Health Care (SE) aims to improve clinical outcomes and streamline workflows, thereby reinforcing its competitive edge in the market. In August Convatec (GB) expanded its product line by acquiring a smaller firm specializing in bioactive wound care technologies. This acquisition not only diversifies Convatec's offerings but also aligns with their strategy to enhance patient care through innovative solutions. The integration of bioactive technologies is anticipated to provide a significant advantage in treating complex wounds, further solidifying Convatec's position in the market. As of November current competitive trends indicate a strong emphasis on digitalization, sustainability, and the integration of AI technologies within the advanced wound-therapy-devices market. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, innovative solutions, and reliable supply chains. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage. ## Recent News & Developments In recent developments within the UK Advanced Wound Therapy Devices Market, companies like Smith and Nephew and Coloplast have made significant strides in expanding their product portfolios, particularly focusing on innovative therapies that address chronic wound care. Notably, in September 2023, ConvaTec announced the acquisition of the wound care division of a smaller firm, enhancing its presence in this competitive sector. This move aligns with the broader trend of consolidation in the market, as companies aim to leverage advanced technologies to improve patient outcomes.  In addition, Medtronic revealed an increase in market valuation driven by extensive Research and Development investments, indicating a robust commitment to enhancing advanced wound management solutions. The market is also witnessing growth, with estimates suggesting a surge in demand due to rising incidences of chronic wounds, which has propelled organizations like 3M and Hollister to invest further in advanced products.  Over the past two years, significant events include ECM Medical's launch of a novel wound healing device in January 2022, showcasing the innovations aimed at addressing various wound care challenges within the UK's healthcare framework. ## Report Scope | MARKET SIZE 2024 | 550.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 580.2(USD Million) | | MARKET SIZE 2035 | 990.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.49% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Smith & Nephew (GB), Mölnlycke Health Care (SE), Acelity (US), Convatec (GB), 3M (US), Medtronic (IE), Hollister Incorporated (US), B. Braun Melsungen AG (DE), Coloplast (DK) | | Segments Covered | Type, End-user | | Key Market Opportunities | Integration of smart technology in advanced wound-therapy-devices enhances patient monitoring and treatment efficacy. | | Key Market Dynamics | Technological advancements drive innovation in advanced wound-therapy-devices, enhancing treatment efficacy and patient outcomes in the UK. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What is the current market valuation of the UK advanced wound-therapy-devices market?** A: The market valuation was $550.0 Million in 2024. **Q: What is the projected market valuation for the UK advanced wound-therapy-devices market by 2035?** A: The market is projected to reach $990.0 Million by 2035. **Q: What is the expected CAGR for the UK advanced wound-therapy-devices market during the forecast period?** A: The expected CAGR is 5.49% from 2025 to 2035. **Q: Which companies are the key players in the UK advanced wound-therapy-devices market?** A: Key players include Smith & Nephew, Mölnlycke Health Care, Acelity, Convatec, 3M, Medtronic, Hollister Incorporated, B. Braun Melsungen AG, and Coloplast. **Q: What are the main segments of the UK advanced wound-therapy-devices market?** A: The main segments include Negative Pressure Wound Therapy Systems, Electric Stimulation Devices, Hyperbaric Oxygen Equipment, and Pressure Relief Devices. **Q: What was the market size for Negative Pressure Wound Therapy Systems in 2024?** A: The market size for Negative Pressure Wound Therapy Systems was $220.0 Million in 2024. **Q: How much is the market for Electric Stimulation Devices expected to grow by 2035?** A: The market for Electric Stimulation Devices is expected to grow from $110.0 Million in 2024 to $200.0 Million by 2035. **Q: What is the projected market size for Home Care Settings in 2035?** A: The projected market size for Home Care Settings is expected to reach $440.0 Million by 2035. **Q: What was the market valuation for Pressure Relief Devices in 2024?** A: The market valuation for Pressure Relief Devices was $110.0 Million in 2024. **Q: What is the expected growth for the Others segment in the UK advanced wound-therapy-devices market?** A: The Others segment is expected to grow from $55.0 Million in 2024 to $90.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-advanced-wound-therapy-devices-market-52855*